Recurrent Ovarian Germ Cell Tumor Recruiting Phase 2 Trials for Metformin (DB00331)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02122185Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerTreatment